Ticker > Company >

Trident Lifeline share price

Trident Lifeline Ltd.

BSE: 543616 SECTOR: Pharmaceuticals & Drugs  27.34 K   63   4

278.00
+3.30 (1.20%)
BSE: 05 Sep 04:01 PM

Price Summary

Today's High

₹ 278

Today's Low

₹ 271

52 Week High

₹ 334

52 Week Low

₹ 222

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

322.26 Cr.

Enterprise Value

322.45 Cr.

No. of Shares

1.16 Cr.

P/E

24.69

P/B

4.5

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  61.81

CASH

6.01 Cr.

DEBT

6.2 Cr.

Promoter Holding

63.04 %

EPS (TTM)

₹  11.26

Sales Growth

40.89%

ROE

14.34 %

ROCE

19.11%

Profit Growth

17.16 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year40.89%
3 Year66.8%
5 YearNA

Profit Growth

1 Year17.16%
3 Year123.33%
5 YearNA

ROE%

1 Year14.34%
3 Year73.87%
5 Year44.32%

ROCE %

1 Year19.11%
3 Year33.11%
5 Year24.8%

Debt/Equity

0.1177

Price to Cash Flow

359.95

Interest Cover Ratio

20.3618

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 63.04 3.46
Mar 2025 63.04 3.46
Dec 2024 62.99 3.46
Sep 2024 62.99 0.00
Jun 2024 65.51 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 123.333080882057% for the Past 3 years.
  • The company has shown a good revenue growth of 66.7963012999551% for the Past 3 years.
  • Company has been maintaining healthy ROE of 73.8690322880373% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.1111348887018% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 20.3618.
  • Company has a healthy liquidity position with current ratio of 3.0501.
  • The company has a high promoter holding of 63.04%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Jun 2024 Sep 2024 Dec 2024 Jun 2025
Net Sales 8.64 14.74 15.66 16.51 18.82
Total Expenditure 6.88 10.66 11.24 12.37 13.89
Operating Profit 1.76 4.08 4.42 4.14 4.93
Other Income 0.33 0.47 0.52 0.54 0.54
Interest 0.1 0.2 0.27 0.35 0.33
Depreciation 0.13 0.33 0.16 0.38 0.51
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.86 4.02 4.52 3.95 4.63
Tax 0.46 1.01 1.13 0.92 1.15
Profit After Tax 1.4 3.01 3.39 3.03 3.48
Adjusted EPS (Rs) 1.22 2.62 2.95 2.63 3.02

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 4.93 9.62 21.77 31.69 44.65
Total Expenditure 5.2 8.37 19.06 25.43 35.78
Operating Profit -0.27 1.25 2.71 6.27 8.87
Other Income 0.07 0.16 0.6 1.15 2.2
Interest 0.76 0.41 0.13 0.48 0.51
Depreciation 0.12 0.14 0.2 0.36 0.77
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.08 0.85 2.98 6.57 9.8
Tax -0.28 0.22 -0.96 0.56 2.76
Net Profit -0.8 0.63 3.95 6.01 7.04
Adjusted EPS (Rs.) -2.57 1.26 4.93 5.23 6.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.1 5 8 11.5 11.5
Total Reserves -6.1 -5.47 -3.22 34.13 41.18
Borrowings 6.46 4.53 1.42 0.46 3.58
Other N/C liabilities -2.01 -1.79 -0.97 -0.45 -0.08
Current liabilities 2.87 7.34 7.61 10.67 17.59
Total Liabilities 4.32 9.6 12.84 56.31 73.78
Assets
Net Block 0.77 1.18 1.43 3.11 7.62
Capital WIP 0 0 0 0.23 4.03
Intangible WIP 0 0 0 0 0
Investments 0 0 0.05 4.04 4.4
Loans & Advances 0.73 0.68 0.67 0.71 4.04
Other N/C Assets 0 0 0 0.03 0.02
Current Assets 2.83 7.74 10.69 48.18 53.67
Total Assets 4.32 9.6 12.84 56.31 73.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -1.08 0.85 2.98 6.57 9.8
Adjustment 0.88 0.55 0.33 0.08 -0.53
Changes in Assets & Liabilities -0.4 0.08 -3.65 -22.72 -5.99
Tax Paid 0 0 0 -0.54 -2.38
Operating Cash Flow -0.59 1.48 -0.19 -16.6 0.9
Investing Cash Flow -0.08 -0.56 -0.5 -5.56 -11.01
Financing Cash Flow 0.76 -0.96 0.8 35.8 2.35
Net Cash Flow 0.08 -0.03 0.11 13.64 -7.76

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 65.51 62.99 62.99 63.04 63.04
amit bhupendra halvawala 1.19 1.19 1.19 1.19 1.19
anjanaben jigishkumar des... 7.03 7.03 7.03 7.03 7.03
hardik jigishkumar desai 22.05 23.50 23.50 23.50 23.50
hardik jigishkumar desai,... 5.47 5.52 5.52 5.57 5.57
mayurkumar mansukhbhai ga... 4.13 4.13 4.13 4.13 4.13
mohak gajera 4.13 4.13 4.13 4.13 4.13
niyati roshan thakkar 1.05 1.05 1.05 1.05 1.05
rinkal mayurbhai gajera 6.80 4.13 4.13 4.13 4.13
rupaben chetanbhai jariwa... 5.84 5.84 5.84 5.84 5.84
tarang nathabhai gajera 5.84 5.84 5.84 5.84 5.84
trident texofab limited - 0.64 0.64 0.64 0.64
trident texofab 1.98 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 34.49 37.01 37.01 36.96 36.96
axita industries private ... 1.02 1.02 1.02 1.02 1.02
chetan muktilal mehta huf... 1.05 1.05 1.05 1.05 1.05
craft emerging market fun... - - - - 1.17
goenka business and finan... 4.65 4.30 4.22 4.22 3.78
llp - 0.01 0.01 - 0.09
nav capital vcc - nav cap... 6.02 6.01 6.01 6.01 6.01

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation H2FY24

Company News

Trident Lifeline - Quaterly Results 28 Jul, 6:45 PM Trident Lifeline - Quaterly Results 28 Jul, 6:45 PM Trident Lifeline - Quaterly Results 28 Jul, 6:45 PM Trident Lifeline informs about board meeting 22 Jul, 5:31 PM Trident Lifeline informs about disclosure 4 Jul, 1:15 PM Trident Lifeline informs about disclosure 4 Jul, 1:11 PM Trident Lifeline informs about outcome of board meeting 1 Jul, 5:56 PM Trident Lifeline informs about disclosure 12 Jun, 12:02 PM Trident Lifeline informs about disclosure 12 Jun, 11:57 AM Trident Lifeline informs about disclosure 12 Jun, 10:56 AM Trident Lifeline’s arm introduces new skincare brand 13 May, 9:41 AM Trident Lifeline informs about disclosure 17 Apr, 2:49 PM Trident Lifeline makes additional investment in subsidiary 17 Apr, 12:42 PM Trident Lifeline partners with National Institutes of Pharmaceutical Education and Research- Ahmedabad 6 Mar, 3:40 PM Trident Lifeline - Quaterly Results 22 Jan, 5:41 PM Trident Lifeline - Quaterly Results 22 Jan, 5:41 PM Trident Lifeline - Quaterly Results 22 Jan, 5:41 PM Trident Lifeline completes acquisition of 50.49% stake in TLL Parenterals 3 Dec, 11:57 AM Trident Lifeline informs about investor presentation 25 Oct, 4:26 PM Trident Lifeline - Quaterly Results 19 Oct, 6:01 PM Trident Lifeline - Quaterly Results 19 Oct, 6:01 PM Trident Lifeline informs about disclosure 28 Sep, 3:27 PM Trident Lifeline informs about disclosure 13 Sep, 5:04 PM Trident Lifeline commences commercial production at manufacturing plant in Surat 13 Sep, 9:39 AM Trident Lifeline informs about disclosure 4 Sep, 12:49 PM Trident Lifeline informs about disclosure 29 Aug, 11:15 AM Trident Lifeline informs about disclosure 29 Aug, 11:14 AM Trident Lifeline informs about disclosure 26 Aug, 5:07 PM Trident Lifeline informs about disclosure 26 Aug, 3:06 PM Trident Lifeline informs about disclosure 23 Aug, 2:50 PM Trident Lifeline informs about disclosure 8 Aug, 10:57 AM Trident Lifeline informs about disclosures 27 Jul, 3:59 PM Trident Lifeline informs about disclosures 27 Jul, 3:56 PM Trident Lifeline informs about disclosures 27 Jul, 3:48 PM Trident Lifeline informs about disclosures 27 Jul, 3:36 PM Trident Lifeline informs about disclosure 25 Jul, 11:03 AM Trident Lifeline - Quaterly Results 17 Jul, 3:44 PM Trident Lifeline - Quaterly Results 17 Jul, 3:44 PM Trident Lifeline - Quaterly Results 17 Jul, 3:44 PM Trident Lifeline informs about disclosure 21 May, 2:11 PM Trident Lifeline informs about disclosures 18 May, 3:05 PM Trident Lifeline informs about disclosure 9 May, 12:15 PM Trident Lifeline’s arm commissions manufacturing facilities at Surat 26 Apr, 3:12 PM Trident Lifeline gets nod to incorporate wholly owned subsidiary 8 Apr, 9:50 AM Trident Lifeline informs about press release 28 Mar, 3:16 PM Trident Lifeline informs about disclosure 22 Mar, 3:24 PM Trident Lifeline informs about disclosure 21 Mar, 10:45 AM Trident Lifeline informs about disclosure 19 Mar, 5:13 PM Trident Lifeline informs about disclosures 13 Mar, 5:09 PM Trident Lifeline informs about disclosures 2 Mar, 4:23 PM

Trident Lifeline Stock Price Analysis and Quick Research Report. Is Trident Lifeline an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Trident Lifeline. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Trident Lifeline has a PE ratio of 24.6926739145882 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Trident Lifeline has ROA of 10.8291% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Trident Lifeline has a Current ratio of 3.0501.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Trident Lifeline has a ROE of 14.3376%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Trident Lifeline has a Debt to Equity ratio of 0.1177 which means that the company has low proportion of debt in its capital.

  • Sales growth: Trident Lifeline has reported revenue growth of 40.894% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Trident Lifeline for the current financial year is 19.8706004604456%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Trident Lifeline is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Trident Lifeline is Rs 11.2584. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Trident Lifeline in Ticker for free. Also, one can get the intrinsic value of Trident Lifeline by using Valuation Calculators, which are available with a Finology ONE subscription. 

Trident Lifeline FAQs

Q1. What is Trident Lifeline share price today?
Ans: The current share price of Trident Lifeline is Rs 278.

Q2. What is the market capitalisation of Trident Lifeline?
Ans: Trident Lifeline has a market capitalisation of Rs 322.26316 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Trident Lifeline?
Ans: The PE ratio of Trident Lifeline is 24.6926739145882 and the P/B ratio of Trident Lifeline is 4.49767593112408, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Trident Lifeline share?
Ans: The 52-week high share price of Trident Lifeline is Rs 334, and the 52-week low share price of Trident Lifeline is Rs 222.

Q5. Does Trident Lifeline pay dividends?
Ans: Currently, Trident Lifeline does not pay dividends. Dividend yield of Trident Lifeline is around 0%.

Q6. What are the face value and book value of Trident Lifeline shares?
Ans: The face value of Trident Lifeline shares is Rs 10, while the book value per share of Trident Lifeline is around Rs 61.8097. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Trident Lifeline?
Ans: Trident Lifeline has a total debt of Rs 6.1956 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Trident Lifeline?
Ans: The ROE of Trident Lifeline is 14.3376% and ROCE of Trident Lifeline is 19.1147%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Trident Lifeline a good buy for the long term?
Ans: The Trident Lifeline long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Trident Lifeline undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Trident Lifeline appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Trident Lifeline’s financials?
Ans: You can review Trident Lifeline’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Trident Lifeline
X